Journal article
A series of pyrimidine-based antifungals with anti-mold activity disrupt ER function in Aspergillus fumigatus
Microbiology spectrum, Vol.12(8), e0104524
06/25/2024
DOI: 10.1128/spectrum.01045-24
PMCID: PMC11302339
PMID: 38916314
Abstract
Fungal infections are a major contributor to morbidity and mortality among immunocompromised populations. Moreover, fungal disease caused by molds are difficult to treat and are associated with particularly high mortality. To address the need for new mold-active antifungal drugs, we performed a high-throughput screen with Aspergillus fumigatus, the most common pathogenic mold. We identified a novel, pyrimidine-based chemical scaffold with broad-spectrum antifungal activity including activity against several difficult-to-treat molds. A chemical genetics screen of Saccharomyces cerevisiae suggested that this compound may target the endoplasmic reticulum (ER) and perturb ER function and/or homeostasis. Consistent with this model, this compound induces the unfolded protein response and inhibits secretion of A. fumigatus collagenases. Initial cytotoxicity and pharmacokinetic studies show favorable features including limited mammalian cell toxicity and bioavailability in vivo. Together, these data support the further medicinal chemistry and pre-clinical development of this pyrimidine scaffold toward more effective treatments for life-threatening invasive mold infections.IMPORTANCEInvasive fungal diseases are life-threatening infections caused by fungi in immunocompromised individuals. Currently, there are only three major classes of antifungal drugs available to treat fungal infections; however, these options are becoming even more limited with the global emergence of antifungal drug resistance. To address the need for new antifungal therapies, we performed a screen of chemical compounds and identified a novel molecule with antifungal activity. Initial characterization of this compound shows drug-like features and broad-spectrum activity against medically important fungi. Together, our results support the continued development of this compound as a potential future therapy for these devastating fungal infections.
Details
- Title: Subtitle
- A series of pyrimidine-based antifungals with anti-mold activity disrupt ER function in Aspergillus fumigatus
- Creators
- Martin T. Kelty - University of IowaAracely Miron-Ocampo - University of IowaSarah R. Beattie - University of Iowa
- Contributors
- Gustavo H. Goldman (Editor)
- Resource Type
- Journal article
- Publication Details
- Microbiology spectrum, Vol.12(8), e0104524
- Publisher
- American Society for Microbiology
- DOI
- 10.1128/spectrum.01045-24
- PMID
- 38916314
- PMCID
- PMC11302339
- ISSN
- 2165-0497
- eISSN
- 2165-0497
- Number of pages
- 20
- Grant note
- 1K12TR004382-01 / HHS | National Institutes of Health (NIH)
- Language
- English
- Electronic publication date
- 06/25/2024
- Academic Unit
- Stead Family Department of Pediatrics; Infectious Disease (Pediatrics)
- Record Identifier
- 9984649053902771
Metrics
9 Record Views